Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

Machiels, J.-P.; Bossi, P.; Menis, J.; Lia, M.; Fortpied, C.; Liu, Y.; Lhommel, R.; Lemort, M.; Schmitz, S.; Canevari, S.; De Cecco, L.; Guzzo, M.; Bianchi, R.; Quattrone, P.; Crippa, F.; Duprez, T.; Lalami, Y.; Quiriny, M.; de Saint Aubain, N.; Clement, P. M.; Coropciuc, R.; Hauben, E.; Licitra, L. F.

Published in

Elsevier, Annals of Oncology, 4(29), p. 985-991, 2018

DOI: 10.1093/annonc/mdy013

Tools

Export citation

Search in Google Scholar

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

Journal article published in 2018 by J.-P. Machiels, P. Bossi, J. Menis, M. Lia, C. Fortpied, Y. Liu, R. Lhommel, M. Lemort, S. Schmitz, S. Canevari, L. De Cecco, M. Guzzo, R. Bianchi, P. Quattrone, F. Crippa and other authors.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)